Yarrow Bioscience, Inc. (YARW)

Yarrow Bioscience Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025
Period Ending	Sep 25, 2026	Dec 31, 2025
Last Close Price	25.54	16.36

Financial Efficiency

Fiscal Year	Current	FY 2025
Period Ending	Sep 25, 2026	Dec 31, 2025
Net Debt / Equity Ratio	-3.46	-3.46
Quick Ratio	1.40	1.40
Current Ratio	1.40	1.40
Return on Capital Employed (ROCE)	-13.80%	-13.80%

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 23, 2026

Data Sources Report a data error